Home › Companies › REVOLUTION MEDICINES INC. › 2024-2025

REVOLUTION MEDICINES INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and REVOLUTION MEDICINES INC.’s Form 8-K, filed 2025-06-27 (Item 5.07 on EDGAR). Page generated 02 October 2026.

8Reported items
283Asset managers
2,296Fund votes
2025-06-26Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore REVOLUTION MEDICINES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by REVOLUTION MEDICINES INC.

These tallies are REVOLUTION MEDICINES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-27 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

REVOLUTION MEDICINES INC. — official shareholder meeting results, meeting held 2025-06-26
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Frank K. Clyburn, Jr.	147,380,169	--	--	512,898	10,241,664	Majority: yes
Elect Director: Sandra J. Horning, M.D.	126,395,644	--	--	21,497,423	10,241,664	Majority: yes
Elect Director: Sushil Patel, Ph.D.	126,396,068	--	--	21,496,999	10,241,664	Majority: yes
Elect Director: Thilo Schroeder, Ph.D.	119,696,091	--	--	28,196,976	10,241,664	Majority: yes
Proposal 2 . The Company's stockholders ratified the appointment, by the audit committee of the Company's board of directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal y	157,875,830	214,963	43,938	--	--	Majority: yes
As a routine proposal under applicable rules, no broker non-votes were recorded in connection with this proposal. Proposal 3 .	145,265,825	2,597,920	29,322	--	10,241,664	Majority: yes

Source: REVOLUTION MEDICINES INC., Form 8-K, filed with the SEC on 2025-06-27 — read the filing on EDGAR.

How asset managers voted at the REVOLUTION MEDICINES INC. 2024-2025 meeting

Each item below shows how the 283 asset managers that disclosed a REVOLUTION MEDICINES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of REVOLUTION MEDICINES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT PURSUANT TO THE COMPENSATION DISCLOSURE RULES OF THE SECURITIES AND EXCHANGE COMMISSION ("SAY-ON-PAY").

SECTION 14A SAY-ON-PAY VOTES

Combines 8 wordings of this item as funds reported it.

98% fund support · no official result

FOR 98%

The 267 asset managers below cast 98% of the shares they voted on this item FOR (166,952,945 for, 2,593,130 against).

FOR: 166,952,945 (98.5%)AGAINST: 2,593,130 (1.5%)ABSTAIN: 26,404 (0.0%)NOT VOTED: 3,017 (0.0%)

Largest asset managers voting on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DI” at REVOLUTION MEDICINES INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	22,646,015	0	For
Fidelity	17,044,110	0	For
T. Rowe Price	12,972,236	0	For
FARALLON CAPITAL MANAGEMENT LLC	12,680,570	0	For
BlackRock	11,004,048	30,757	For
Wellington	9,611,508	0	For
Janus Henderson	7,773,119	0	For
State Street	7,261,219	1,114	For
BVF INC/IL	4,982,384	0	For
JANUS INVESTMENT FUND	4,687,672	0	For
GEODE CAPITAL MANAGEMENT, LLC	4,178,816	0	For
GV Management Company, L.L.C.	4,080,700	0	For
Holocene Advisors, LP	4,012,457	0	For
Charles Schwab	3,954,885	0	For
Woodline Partners LP	3,453,683	0	For
Paradigm Biocapital Advisors LP	3,388,995	0	For
DEERFIELD MANAGEMENT COMPANY, L.P.	3,384,072	0	For
AH Capital Management, L.L.C.	2,748,523	0	For
JPMorgan	1,693,219	0	For
Hood River Capital Management LLC	1,664,162	0	For
Northern Trust	1,351,388	0	For
Casdin Capital, LLC	1,277,463	0	For
American Century	0	1,260,040	Against
AMERIPRISE FINANCIAL INC	1,144,288	0	For
WESTFIELD CAPITAL MANAGEMENT CO LP	1,019,407	40,210	For

Showing the 25 largest of 267 asset managers. See all 267 in the interactive database.

2. To elect four Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until his or her successor is elected: Frank K. Clyburn, Jr.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%

FOR: 147,380,169WITHHELD: 512,898

REVOLUTION MEDICINES INC.’s own tally for this item (“Elect Director: Frank K. Clyburn, Jr.”): 147,380,169 for, 512,898 withheld, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 186,258,206 outstanding shares: 79% for, 0.3% withheld (79% of the company cast a for/withheld vote).

The 83 asset managers below cast 100% of the shares they voted on this item FOR (61,586,145 for, 0 against).

FOR 99.9%

FOR: 61,586,145 (100.0%)ABSTAIN: 15,382 (0.0%)NOT VOTED: 87 (0.0%)

Largest asset managers voting on “To elect four Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until his or ” at REVOLUTION MEDICINES INC., 2024-2025
Asset manager	For	Vote
Vanguard	22,155,786	For
Fidelity	9,184,298	For
T. Rowe Price	5,370,441	For
BlackRock	5,206,044	For
JANUS INVESTMENT FUND	4,687,672	For
State Street	1,992,023	For
Charles Schwab	1,964,933	For
JPMorgan	1,675,427	For
Manager Directed Portfolios	956,381	For
Equitable	632,050	For
American Century	612,358	For
Hartford	502,646	For
Jackson National	489,322	For
Goldman Sachs	462,975	For
TIAA	453,946	For
MUTUAL FUND SERIES TRUST	372,229	For
Columbia Threadneedle	368,255	For
Victory Capital	359,708	For
HARBOR FUNDS	342,009	For
QUANTITATIVE MASTER SERIES LLC	292,934	For
Voya	292,649	For
Bridge Builder Trust	287,303	For
John Hancock	267,567	For
AIG/SunAmerica	248,049	For
Lincoln Financial	180,341	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

3. To elect four Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until his or her successor is elected: Sandra J. Horning, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD 15%

FOR: 126,395,644WITHHELD: 21,497,423

REVOLUTION MEDICINES INC.’s own tally for this item (“Elect Director: Sandra J. Horning, M.D.”): 126,395,644 for, 21,497,423 withheld, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 186,258,206 outstanding shares: 68% for, 12% withheld (79% of the company cast a for/withheld vote).

The 83 asset managers below cast 100% of the shares they voted on this item FOR (58,624,501 for, 0 against).

FOR 95%

FOR: 58,624,501 (95.2%)ABSTAIN: 2,977,027 (4.8%)NOT VOTED: 87 (0.0%)

Largest asset managers voting on “To elect four Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until his or ” at REVOLUTION MEDICINES INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	22,155,786	0	For
Fidelity	9,184,298	0	For
T. Rowe Price	5,370,441	0	For
BlackRock	5,206,044	0	For
JANUS INVESTMENT FUND	4,687,672	0	For
State Street	1,979,282	12,741	For
Charles Schwab	1,964,933	0	For
JPMorgan	1,675,427	0	For
Manager Directed Portfolios	956,381	0	For
Equitable	441,422	190,628	For
American Century	0	612,358	Abstain
Hartford	502,646	0	For
Jackson National	374,753	114,569	For
Goldman Sachs	429,405	33,570	For
TIAA	453,946	0	For
MUTUAL FUND SERIES TRUST	372,229	0	For
Columbia Threadneedle	368,255	0	For
Victory Capital	1,607	358,101	Abstain
HARBOR FUNDS	0	342,009	Abstain
QUANTITATIVE MASTER SERIES LLC	292,934	0	For
Voya	292,649	0	For
Bridge Builder Trust	50,231	237,072	Abstain
John Hancock	95,932	171,635	Abstain
AIG/SunAmerica	0	248,049	Abstain
Lincoln Financial	180,341	0	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

4. To elect four Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until his or her successor is elected: Sushil Patel, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD 15%

FOR: 126,396,068WITHHELD: 21,496,999

REVOLUTION MEDICINES INC.’s own tally for this item (“Elect Director: Sushil Patel, Ph.D.”): 126,396,068 for, 21,496,999 withheld, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 186,258,206 outstanding shares: 68% for, 12% withheld (79% of the company cast a for/withheld vote).

The 83 asset managers below cast 100% of the shares they voted on this item FOR (58,624,501 for, 0 against).

FOR 95%

FOR: 58,624,501 (95.2%)ABSTAIN: 2,977,027 (4.8%)NOT VOTED: 87 (0.0%)

Largest asset managers voting on “To elect four Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until his or ” at REVOLUTION MEDICINES INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	22,155,786	0	For
Fidelity	9,184,298	0	For
T. Rowe Price	5,370,441	0	For
BlackRock	5,206,044	0	For
JANUS INVESTMENT FUND	4,687,672	0	For
State Street	1,979,282	12,741	For
Charles Schwab	1,964,933	0	For
JPMorgan	1,675,427	0	For
Manager Directed Portfolios	956,381	0	For
Equitable	441,422	190,628	For
American Century	0	612,358	Abstain
Hartford	502,646	0	For
Jackson National	374,753	114,569	For
Goldman Sachs	429,405	33,570	For
TIAA	453,946	0	For
MUTUAL FUND SERIES TRUST	372,229	0	For
Columbia Threadneedle	368,255	0	For
Victory Capital	1,607	358,101	Abstain
HARBOR FUNDS	0	342,009	Abstain
QUANTITATIVE MASTER SERIES LLC	292,934	0	For
Voya	292,649	0	For
Bridge Builder Trust	50,231	237,072	Abstain
John Hancock	95,932	171,635	Abstain
AIG/SunAmerica	0	248,049	Abstain
Lincoln Financial	180,341	0	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

5. To elect four Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until his or her successor is elected: Thilo Schroeder, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%WITHHELD 19%

FOR: 119,696,091WITHHELD: 28,196,976

REVOLUTION MEDICINES INC.’s own tally for this item (“Elect Director: Thilo Schroeder, Ph.D.”): 119,696,091 for, 28,196,976 withheld, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 186,258,206 outstanding shares: 64% for, 15% withheld (79% of the company cast a for/withheld vote).

The 83 asset managers below cast 100% of the shares they voted on this item FOR (56,429,984 for, 0 against).

FOR 92%8%

FOR: 56,429,984 (91.6%)ABSTAIN: 5,171,544 (8.4%)NOT VOTED: 87 (0.0%)

Largest asset managers voting on “To elect four Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until his or ” at REVOLUTION MEDICINES INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	22,155,786	0	For
Fidelity	9,184,298	0	For
T. Rowe Price	5,370,441	0	For
BlackRock	5,206,044	0	For
JANUS INVESTMENT FUND	4,687,672	0	For
State Street	5,668	1,986,355	Abstain
Charles Schwab	1,964,933	0	For
JPMorgan	1,675,427	0	For
Manager Directed Portfolios	956,381	0	For
Equitable	441,422	190,628	For
American Century	0	612,358	Abstain
Hartford	502,646	0	For
Jackson National	374,753	114,569	For
Goldman Sachs	429,405	33,570	For
TIAA	453,946	0	For
MUTUAL FUND SERIES TRUST	372,229	0	For
Columbia Threadneedle	368,255	0	For
Victory Capital	1,607	358,101	Abstain
HARBOR FUNDS	0	342,009	Abstain
QUANTITATIVE MASTER SERIES LLC	292,934	0	For
Voya	292,649	0	For
Bridge Builder Trust	50,231	237,072	Abstain
John Hancock	95,932	171,635	Abstain
AIG/SunAmerica	0	248,049	Abstain
Lincoln Financial	54,529	125,812	Abstain

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

6. To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025; and

AUDIT-RELATEDMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%

FOR: 157,875,830AGAINST: 214,963

REVOLUTION MEDICINES INC.’s own tally for this item (“Proposal 2 . The Company's stockholders ratified the appointment, by the audit committee of the Company's board of directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Comp”): 157,875,830 for, 214,963 against, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 186,258,206 outstanding shares: 85% for, 0.2% against (85% of the company cast a for/against vote).

The 83 asset managers below cast 99.9% of the shares they voted on this item FOR (61,589,923 for, 852 against).

FOR 99.9%

FOR: 61,589,923 (100.0%)AGAINST: 852 (0.0%)ABSTAIN: 10,752 (0.0%)NOT VOTED: 87 (0.0%)

Largest asset managers voting on “To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoope” at REVOLUTION MEDICINES INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	22,155,786	0	For
Fidelity	9,184,298	0	For
T. Rowe Price	5,370,441	0	For
BlackRock	5,206,044	0	For
JANUS INVESTMENT FUND	4,687,672	0	For
State Street	1,991,908	115	For
Charles Schwab	1,964,933	0	For
JPMorgan	1,675,427	0	For
Manager Directed Portfolios	956,381	0	For
Equitable	632,050	0	For
American Century	612,358	0	For
Hartford	502,646	0	For
Jackson National	489,322	0	For
Goldman Sachs	462,975	0	For
TIAA	453,946	0	For
MUTUAL FUND SERIES TRUST	372,229	0	For
Columbia Threadneedle	368,255	0	For
Victory Capital	359,708	0	For
HARBOR FUNDS	342,009	0	For
QUANTITATIVE MASTER SERIES LLC	292,934	0	For
Voya	292,649	0	For
Bridge Builder Trust	287,303	0	For
John Hancock	267,567	0	For
AIG/SunAmerica	248,049	0	For
Lincoln Financial	180,341	0	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

7. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

97% fund support · no official result

FOR 97%

The 7 asset managers below cast 97% of the shares they voted on this item FOR (3,651,532 for, 106,360 against).

FOR: 3,651,532 (97.2%)AGAINST: 106,360 (2.8%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at REVOLUTION MEDICINES INC., 2024-2025
Asset manager	For	Against	Vote
JPMorgan	3,195,840	0	For
ADAGE CAPITAL PARTNERS GP, L.L.C.	344,000	0	For
Desjardins Global Asset Management Inc.	0	106,360	Against
Granahan Investment Management, LLC	78,829	0	For
Metzler Asset Management GmbH	25,821	0	For
Jasper Ridge Partners, L.P.	3,737	0	For
HC CAPITAL TRUST	3,305	0	For

8. To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say on Pay").

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (997,455 for, 0 against).

FOR: 997,455 (100.0%)

Largest asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as di” at REVOLUTION MEDICINES INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Frazier Life Sciences Management, L.P.	997,455	0	0	0	For
Checkpoint Capital L.P.	0	0	0	0	--

Largest REVOLUTION MEDICINES INC. shareholders voting in 2024-2025

Ranked by the number of REVOLUTION MEDICINES INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 186,258,206 shares outstanding at the time of that meeting.

Top REVOLUTION MEDICINES INC. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	Vanguard	12.16%
2	Fidelity	9.15%
3	T. Rowe Price	6.96%
4	FARALLON CAPITAL MANAGEMENT LLC	6.81%
5	BlackRock	5.92%
6	Wellington	5.16%
7	Janus Henderson	4.17%
8	State Street	3.90%
9	BVF INC/IL	2.67%
10	JANUS INVESTMENT FUND	2.52%

Reported REVOLUTION MEDICINES INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

REVOLUTION MEDICINES INC. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
Vanguard Group	8.92%	13F
BlackRock	7.89%	13F
Farallon Partners, L.L.C.	7.64%	13G
Wellington Management	6.33%	13F
Entities affiliated with Wellington Management Group	6.12%	DEF14A
JANUS HENDERSON GROUP PLC	5.24%	13G
Baker Bros. Advisors LP	5.08%	13G
Thilo Schroeder, Ph.D.	4.08%	DEF14A
FMR (Fidelity)	4.05%	13F
State Street	3.12%	13F

Percentages above are of 186,258,206 shares outstanding, as reported by REVOLUTION MEDICINES INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from REVOLUTION MEDICINES INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At REVOLUTION MEDICINES INC.'s shareholder meeting held 2025-06-26, in the 2024-2025 proxy season, 283 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,296 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. REVOLUTION MEDICINES INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE… — the reporting funds cast 98% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

REVOLUTION MEDICINES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.